An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes (MOSAIc)

Lilly

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Study type: Observational

Funder types: Industry

Identifiers

NCT01400971

F3Z-MC-B010 (Other Identifier)

14056

Details and patient eligibility

About

The purpose of this study is to identify specific patient, physician, and health system related factors associated with the progression to a more intensive regimen from initial insulin therapy for patients with type 2 diabetes.

Enrollment: 4,299 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have been diagnosed with type 2 diabetes
• Have presented within the normal course of care
• Have been on their initial insulin therapy for ≥3 months (with or without any combination of approved non-insulin anti-diabetic medications)
• Are not simultaneously participating in a study that includes an investigational drug or procedure at entry into the study
• Have been fully informed and have given written consent for the use of their data
• Have a sufficient understanding of the primary language of the country such that they will be able to complete the questionnaires
• Have not initiated basal bolus therapy (three mealtime insulin injections)

Exclusion criteria

• None

Trial design

4,299 participants in 1 patient group

MOSAIc Participants

Description:

Participants enrolled in Multinational Observational Study Assessing Insulin use (MOSAIc) who had complete treatment data during the study.